270 related articles for article (PubMed ID: 16377382)
1. Evidence-based systematic literature review of hemoglobin/hematocrit and all-cause mortality in dialysis patients.
Volkova N; Arab L
Am J Kidney Dis; 2006 Jan; 47(1):24-36. PubMed ID: 16377382
[TBL] [Abstract][Full Text] [Related]
2. Haemoglobin and haematocrit targets for the anaemia of chronic renal disease.
Strippoli GF; Manno C; Schena FP; Craig JC
Cochrane Database Syst Rev; 2003; (1):CD003967. PubMed ID: 12535495
[TBL] [Abstract][Full Text] [Related]
3. Should the hematocrit be normalized in dialysis and in pre-ESRD patients?
Macdougall IC
Blood Purif; 2001; 19(2):157-67. PubMed ID: 11150803
[No Abstract] [Full Text] [Related]
4. [A hematocrit greater than 36 lessens mortality and hospitalization in hemodialysis].
Fernández-Gallego J; Gutiérrez C
Nefrologia; 2003; 23(2):177-8. PubMed ID: 12778885
[No Abstract] [Full Text] [Related]
5. Anemia, hospitalization, and mortality in patients receiving peritoneal dialysis in the United States.
Li S; Foley RN; Collins AJ
Kidney Int; 2004 May; 65(5):1864-9. PubMed ID: 15086928
[TBL] [Abstract][Full Text] [Related]
6. Association of quarterly average achieved hematocrit with mortality in dialysis patients: a time-dependent comorbidity-adjusted model.
Messana JM; Chuang CC; Turenne M; Wheeler J; Turner J; Sleeman K; Tedeschi P; Hirth R
Am J Kidney Dis; 2009 Mar; 53(3):503-12. PubMed ID: 19185402
[TBL] [Abstract][Full Text] [Related]
7. Should the hematocrit (hemoglobin) be normalized in Pre-ESRD or dialysis patients? Yes!
Besarab A; Aslam M
Blood Purif; 2001; 19(2):168-74. PubMed ID: 11150804
[No Abstract] [Full Text] [Related]
8. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F
Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875
[TBL] [Abstract][Full Text] [Related]
9. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
10. Influence of target hemoglobin in dialysis patients on morbidity and mortality.
Collins AJ
Kidney Int Suppl; 2002 May; (80):44-8. PubMed ID: 11982812
[TBL] [Abstract][Full Text] [Related]
11. Hemoglobin predicts long-term survival in dialysis patients: a 15-year single-center longitudinal study and a correlation trend between prealbumin and hemoglobin.
Avram MM; Blaustein D; Fein PA; Goel N; Chattopadhyay J; Mittman N
Kidney Int Suppl; 2003 Nov; (87):S6-11. PubMed ID: 14531767
[TBL] [Abstract][Full Text] [Related]
12. Trends in anemia treatment with erythropoietin usage and patient outcomes.
Collins AJ; Ma JZ; Xia A; Ebben J
Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S133-41. PubMed ID: 9892380
[TBL] [Abstract][Full Text] [Related]
13. Target hemoglobin level for EPO therapy in CKD.
Parfrey PS
Am J Kidney Dis; 2006 Jan; 47(1):171-3. PubMed ID: 16377399
[No Abstract] [Full Text] [Related]
14. Morbidity and mortality in patients on dialysis: the impact of hemoglobin levels.
Brattich M
Nephrol Nurs J; 2006; 33(1):64-7, 90; quiz 68-9. PubMed ID: 16538929
[TBL] [Abstract][Full Text] [Related]
15. Relationships between hemoglobin and hematocrit levels and hospitalization and survival rates in dialysis patients.
Brattich M
Nephrol Nurs J; 2003 Apr; 30(2):231-4. PubMed ID: 12737001
[TBL] [Abstract][Full Text] [Related]
16. Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization.
Servilla KS; Singh AK; Hunt WC; Harford AM; Miskulin D; Meyer KB; Bedrick EJ; Rohrscheib MR; Tzamaloukas AH; Johnson HK; Zager PG
Am J Kidney Dis; 2009 Sep; 54(3):498-510. PubMed ID: 19628315
[TBL] [Abstract][Full Text] [Related]
17. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
[TBL] [Abstract][Full Text] [Related]
18. UK Renal Registry 16th annual report: chapter 10 haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2012: national and centre-specific analyses.
Rao A; Gilg J; Williams A
Nephron Clin Pract; 2013; 125(1-4):183-208. PubMed ID: 24662174
[TBL] [Abstract][Full Text] [Related]
19. Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials.
Strippoli GF; Craig JC; Manno C; Schena FP
J Am Soc Nephrol; 2004 Dec; 15(12):3154-65. PubMed ID: 15579519
[TBL] [Abstract][Full Text] [Related]
20. Dialysis dose, membrane type, and anemia control.
Young EW
Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S157-60. PubMed ID: 9892384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]